MitchellRosner United StatesUniveristy of Virginia Health

MitchellRosner
Mitchell H. Rosner, MD, FACPrChairman, Department of MedicinerAssociate Professor of MedicinerUniversity of Virginia Health SystemrCharlottesville, VirginiarrMitchell Rosner, MD, FACP is the Henry B. Mulholland Professor of Medicine in the Division of Nephrology and Chairman for the Department of Medicine at the University of Virginia. He received his medical degree from the Medical College of Georgia, and completed his residency and a fellowship at the University of Virginia. He is board certified in internal medicine and nephrology.rrDr. Rosner has a strong interest in education and serves on a number of national committees devoted to educational aspects of medical training. Dr. Rosner is the recipient of numerous honors including the University of Virginia All-University Teaching Award and the University Master Educator Award. rrHis clinical practice focus is the medical care of patients with all forms of kidney disease—from acute kidney failure to end-stage kidney disease. His special interest in patients with polycystic kidney disease led Dr. Rosner to found the first regional clinic to specifically address the clinical management of patients with polycystic kidney disease. Dr. Rosner serves as the medical director for this multidisciplinary, patient-centered clinic that also provides selected patients the opportunity to enroll in clinical trials investigating novel therapies for this disease. rrHis research interests include the pathogenesis and management of disorders of sodium and water balance, the treatment of polycystic kidney disease, and the development of novel therapeutics for acute kidney injury. Most recently, he chaired the international consensus group on exercise-associated hyponatremia.rrDr. Rosner has published over 100 articles in peer-reviewed medical journals, and serves on the editorial boards of numerous journals including the American Journal of Kidney Disease and the Clinical Journal of the American Society of Nephrology
Institution

Day 1 - Sunday April 14, 2024

Time Session
3 p.m.
4 p.m.
LF1007
Angela Yee-MoonWang Chairperson SingaporeHong Kong/Singapore
ThiagoDe Azevedo Reis Chairperson thiagoreisnefro@gmail.comBrazilHospital Sírio-Libanês, São Paulo, Brazil & Fenix
  • Is Magnesium a Missing Puzzle for Vascular Calcification in CKD?
    SolaAoun Bahous Speaker sola.bahous@gmail.comLebanonLebanese American University School of Medicine
  • Should Potassium Be Restricted or Not in CKD?
    RobertoPecoits Filho Speaker United StatesArbor Research Collaborative for Health
  • Metabolic Acidosis in CKD: When to Treat? What to Target?
    MitchellRosner Speaker United StatesUniveristy of Virginia Health
  • Q and A
Hall A

Day 2 - Monday April 15, 2024

Time Session
3 p.m.
4 p.m.
LF1005
MitchellRosner Chairperson United StatesUniveristy of Virginia Health
  • Overview of Hyponatremia
    Angela Yee-MoonWang Speaker SingaporeHong Kong/Singapore
  • Pro: Current Guidelines are Appropriate
    HelbertRondon-Berrios Speaker rondonberriosh@upmc.eduUnited StatesUniversity of Pittsburgh School of Medicine
  • Con: Current Guidelines are Too Conservative
    CarlosAyus Speaker carlosayus@yahoo.comUnited StatesUniversity of California Irvine
  • Discussion
Hall C3

Pre-Congress - Saturday April 13, 2024

Time Session
9 a.m.
11 a.m.
NAR1
MatiasFerrari Chairperson ferrarimatias89@gmail.comArgentinaSAN
MitchellRosner Chairperson United StatesUniveristy of Virginia Health
MoumitaBarua Chairperson moumita.barua@uhn.caCanada
YelenaDrexler Chairperson yrd6@miami.eduUnited StatesUniversity of Miami Miller School of Medicine
  • Changing Paradigms in the Care of Acute Kidney Injury
    MarliesOstermann Speaker United KingdomKing's College London
  • Update on Electrolyte Disorders
    MitchellRosner Speaker United StatesUniveristy of Virginia Health
  • How to Incorporate Genetic Testing in Nephrology
    MoumitaBarua Speaker moumita.barua@uhn.caCanada
  • Glomerular Diseases: Case Presentation
    MatiasFerrari Speaker ferrarimatias89@gmail.comArgentinaSAN
  • Q and A
Hall C4
11:30 a.m.
1:30 p.m.
NAR2
MatiasFerrari Chairperson ferrarimatias89@gmail.comArgentinaSAN
MitchellRosner Chairperson United StatesUniveristy of Virginia Health
MoumitaBarua Chairperson moumita.barua@uhn.caCanada
YelenaDrexler Chairperson yrd6@miami.eduUnited StatesUniversity of Miami Miller School of Medicine
  • Changing Paradigms in the Care of Chronic Kidney Disease: Slowing Progression
    Magdalena Madero Speaker MexicoChief of Nephrology, Instituto Nacional de Cardiol
  • What
    ThiagoDe Azevedo Reis Speaker thiagoreisnefro@gmail.comBrazilHospital Sírio-Libanês, São Paulo, Brazil & Fenix
  • Therapeutic Approaches for Polycystic Kidney Disease
    Roman-UlrichMueller Speaker roman-ulrich.mueller@uk-koeln.deGermanyUniversity of Cologne
  • Glomerular Diseases: Case Presentation
    MatiasFerrari Speaker ferrarimatias89@gmail.comArgentinaSAN
  • Q and A
Hall C4
2:15 p.m.
4:15 p.m.
NAR3
MatiasFerrari Chairperson ferrarimatias89@gmail.comArgentinaSAN
MitchellRosner Chairperson United StatesUniveristy of Virginia Health
MoumitaBarua Chairperson moumita.barua@uhn.caCanada
YelenaDrexler Chairperson yrd6@miami.eduUnited StatesUniversity of Miami Miller School of Medicine
  • Glomerular Diseases: Update
    YelenaDrexler Speaker yrd6@miami.eduUnited StatesUniversity of Miami Miller School of Medicine
  • Transplantation 2023 and Beyond
    ShrutiTapiawala Speaker IndiaGleneagles Hospital Mumbai , Sir HN Reliance Foundation Hospital and Research Center, Mumbai
  • Hypertension and the Kidney
    GeorgeThomas Speaker thomasg3@ccf.orgUnited StatesASN
  • Glomerular Diseases: Case Presentation
    MatiasFerrari Speaker ferrarimatias89@gmail.comArgentinaSAN
  • Q and A
Hall C4